Form 8-K - Current report:
SEC Accession No. 0001213900-24-080719
Filing Date
2024-09-20
Accepted
2024-09-20 17:00:30
Documents
13
Period of Report
2024-09-20
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0215273-8k_therap.htm   iXBRL 8-K 24968
  Complete submission text file 0001213900-24-080719.txt   202412

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE txmd-20240920.xsd EX-101.SCH 3033
3 XBRL LABEL FILE txmd-20240920_lab.xml EX-101.LAB 34916
4 XBRL PRESENTATION FILE txmd-20240920_pre.xml EX-101.PRE 22801
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0215273-8k_therap_htm.xml XML 3845
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 241314014
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)